相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
Carl M. Gay et al.
CANCER CELL (2021)
Profiling of Circulating Free DNA Using Targeted and Genome-wide Sequencing in Patients with SCLC
Sumitra Mohan et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses
Taofeek K. Owonikoko et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
Dynamically Monitoring the Clonal Evolution of Lung Cancer Based on the Molecular Characterization of Circulating Tumor Cells Using Aptamer Cocktail-Modified Nanosubstrates
Ying Zhu et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
Early Detection of Multiple Resistance Mechanisms by ctDNA Profiling in a Patient With EGFR-mutant Lung Adenocarcinoma Treated With Osimertinib
Sabine Schmid et al.
CLINICAL LUNG CANCER (2020)
Clinical potential of ctDNA-based TMB in small cell lung cancer recieving chemoradiotherapy.
Ying Jin et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention
Anne Marie Lennon et al.
SCIENCE (2020)
Targeted Therapies and Biomarkers in Small Cell Lung Cancer
Hirokazu Taniguchi et al.
FRONTIERS IN ONCOLOGY (2020)
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
M. C. Liu et al.
ANNALS OF ONCOLOGY (2020)
Circulating Tumor DNA as a Prognostic Determinant in Small Cell Lung Cancer Patients Receiving Atezolizumab
Guillaume Herbreteau et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Combination of tissue and liquid biopsy molecular profiling to detect transformation to small cell lung carcinoma during osimertinib treatment
Julie A. Vendrell et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Circulating tumor cells as a new predictive and prognostic factor in patients with small cell lung cancer
Pei-Pei Wang et al.
JOURNAL OF CANCER (2020)
Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer
C. Allison Stewart et al.
NATURE CANCER (2020)
Baseline Tumor Size as a Predictive and Prognostic Factor of Immune Checkpoint Inhibitor Therapy for Non-small Cell Lung Cancer
Masahiro Katsurada et al.
ANTICANCER RESEARCH (2019)
Prognostic value of circulating tumour cells in limited-stage small-cell lung cancer: analysis of the concurrent once-daily versus twice-daily radiotherapy (CONVERT) randomised controlled trial
R. Y. Tay et al.
ANNALS OF ONCOLOGY (2019)
Inferring the Evolution and Progression of Small-Cell Lung Cancer by Single-Cell Sequencing of Circulating Tumor Cells
Zhe Su et al.
CLINICAL CANCER RESEARCH (2019)
Durvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II Study
Anish Thomas et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Circulating Tumor DNA Profiling in Small-Cell Lung Cancer Identifies Potentially Targetable Alterations
Siddhartha Devarakonda et al.
CLINICAL CANCER RESEARCH (2019)
Molecular analysis of cell-free DNA identifies distinct molecular features in patients with chemosensitive and chemorefractory small cell lung cancer
Jie Zhang et al.
CANCER COMMUNICATIONS (2019)
Liquid biopsy for rectal cancer: A systematic review
Daniela Massihnia et al.
CANCER TREATMENT REVIEWS (2019)
Characterization of DLL3-positive circulating tumor cells (CTCs) in patients with small cell lung cancer (SCLC) and evaluation of their clinical relevance during front-line treatment
Ippokratis Messaritakis et al.
LUNG CANCER (2019)
Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer
Anna F. Farago et al.
CANCER DISCOVERY (2019)
1744PMutational profiling of tumour tissue and sequential plasma illustrates emergent clones during treatment in late stage small cell lung cancer (SCLC)
S Yaung et al.
ANNALS OF ONCOLOGY (2019)
Circulating tumor DNA analysis in breast cancer: Is it ready for prime-time?
Giuseppe Buono et al.
CANCER TREATMENT REVIEWS (2019)
Dynamics of multiple resistance mechanisms in plasma DNA during EGFR-targeted therapies in non-small cell lung cancer
Dana Wai Yi Tsui et al.
EMBO MOLECULAR MEDICINE (2018)
Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer
M. Catherine Pietanza et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Longitudinal Cell-Free DNA Analysis in Patients with Small Cell Lung Cancer Reveals Dynamic Insights into Treatment Efficacy and Disease Relapse
Karinna Almodovar et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC
Christian Rolfo et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Phase II Study of Maintenance Pembrolizumab in Patients with Extensive-Stage Small Cell Lung Cancer (SCLC)
Shirish M. Gadgeel et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Genomic alterations of plasma cell-free DNAs in small cell lung cancer and their clinical relevance
Meijun Du et al.
LUNG CANCER (2018)
Primary resistance to osimertinib due to SCLC transformation: Issue of T790M determination on liquid re-biopsy
R. Minari et al.
LUNG CANCER (2018)
Dynamic changes of phenotypically different circulating tumor cells sub-populations in patients with recurrent/refractory small cell lung cancer treated with pazopanib
Ippokratis Messaritakis et al.
SCIENTIFIC REPORTS (2018)
Dynamic Changes and Drug-Induced Selection of Resistant Clones in a Patient With EGFR-Mutated Adenocarcinoma That Acquired T790M Mutation and Transformed to Small-Cell Lung Cancer
Yuki Iijima et al.
CLINICAL LUNG CANCER (2018)
Prevalence of clonal hematopoiesis of indeterminate potential (CHIP) measured by an ultra-sensitive sequencing assay: Exploratory analysis of the Circulating Cancer Genome Atlas (CCGA) study.
Charles Swanton et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Early assessment of therapy response in small cell lung cancer via longitudinal ctDNA analysis.
John F. Palma et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Will liquid biopsies improve outcomes for patients with small-cell lung cancer?
Fiona Blackhall et al.
LANCET ONCOLOGY (2018)
Bcl-2 expression in circulating tumor cells (CTCs) of patients with small cell lung cancer (SCLC) receiving front-line treatment
Ippokratis Messaritakis et al.
LUNG CANCER (2018)
Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer
Jingying Nong et al.
NATURE COMMUNICATIONS (2018)
170PEcological diversity indices as measurements of tumor heterogeneity correlates with clinical outcomes in late stage small cell lung cancer (SCLC)
S Yaung et al.
ANNALS OF ONCOLOGY (2018)
Successful sequential treatment of refractory tumors caused by small cell carcinoma transformation and EGFR-T790M mutation diagnosed by repeated genetic testing in a patient with lung adenocarcinoma harboring epidermal growth factor receptor mutations: A case report
Naoya Nishioka et al.
RESPIRATORY MEDICINE CASE REPORTS (2018)
Incorporation of circulating tumor cells and whole-body metabolic tumor volume of 18F-FDG PET/CT improves prediction of outcome in IIIB stage small-cell lung cancer
Lei Fu et al.
CHINESE JOURNAL OF CANCER RESEARCH (2018)
Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancer
Louise Carter et al.
NATURE MEDICINE (2017)
Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer: exploratory analysis of a phase II study
Ravi Salgia et al.
INVESTIGATIONAL NEW DRUGS (2017)
The Potential of ctDNA Sequencing in Disease Monitoring and Depicting Genomic Evolution of Small-Cell Lung Cancer Under Therapy
J. Wang et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Molecular Mechanism of Transformation from Adenocarcinoma to Small-Cell Lung Cancer after EGFR-TKI
Jiefei Han et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
A Pilot Study to Assess Circulating Tumor Cells, Circulating Tumor Cell DNA and Cell Free DNA in Patients with Small Cell Lung Cancer
Charu Aggarwal et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Dual occurrence of ALK G1202R solvent front mutation and small cell lung cancer transformation as resistance mechanisms to second generation ALK inhibitors without prior exposure to crizotinib. Pitfall of solely relying on liquid re-biopsy?
Sai-Hong Ignatius Ou et al.
LUNG CANCER (2017)
Circulating tumor cells as a predictive biomarker in patients with small cell lung cancer undergoing chemotherapy
Charu Aggarwal et al.
LUNG CANCER (2017)
Unravelling the biology of SCLC: implications for therapy
Joshua K. Sabari et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Clinical significance of circulating tumor cells in patients with small-cell lung cancer
Yu-Li Wang et al.
TUMORI JOURNAL (2017)
Predictive and prognostic value of folate receptor-positive circulating tumor cells in small cell lung cancer patients treated with first-line chemotherapy
Jiqiao Shen et al.
ONCOTARGET (2017)
Dynamics of EGFR mutations in plasma recapitulates the clinical response to EGFR-TKIs in NSCLC patients
Liwen Xiong et al.
ONCOTARGET (2017)
Clinical significance of circulating tumor cells in patients with small-cell lung cancer
Yu-Li Wang et al.
TUMORI JOURNAL (2017)
TTF-1-and/or CD56-positive Circulating Tumor Cells in patients with small cell lung cancer (SCLC)
Ippokratis Messaritakis et al.
SCIENTIFIC REPORTS (2017)
Circulating tumor cell status monitors the treatment responses in breast cancer patients: a meta-analysis
Wen-Ting Yan et al.
SCIENTIFIC REPORTS (2017)
Clonal Evolution and the Role of Serial Liquid Biopsies in a Case of Small-Cell Lung Cancer-Transformed EGFR Mutant Non-Small-Cell Lung Cancer
Meghan J. Mooradian et al.
JCO PRECISION ONCOLOGY (2017)
Second-line pazopanib in patients with relapsed and refractory small-cell lung cancer: a multicentre phase II study of the Hellenic Oncology Research Group
F. Koinis et al.
BRITISH JOURNAL OF CANCER (2017)
Clinical correlation of extensive-stage small-cell lung cancer genomics
A. Dowlati et al.
ANNALS OF ONCOLOGY (2016)
Evaluation of Circulating Tumor Cells in Predicting Therapeutic Response in Small Cell Lung Cancer Patients
Xu Wang et al.
ARCHIVES OF MEDICAL RESEARCH (2016)
Vismodegib or cixutumumab in combination with standard chemotherapy for patients with extensive-stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E1508)
Chandra P. Belani et al.
CANCER (2016)
Circulating tumor cell counts/change for outcome prediction in patients with extensive-stage small-cell lung cancer
Ying Cheng et al.
FUTURE ONCOLOGY (2016)
A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer
M. Catherine Pietanza et al.
LUNG CANCER (2016)
Small cell lung cancer transformation and the T790M mutation: A case report of two acquired mechanisms of TKI resistance detected in a tumor rebiopsy and plasma sample of EGFR-mutant lung adenocarcinoma
Greta Ali et al.
ONCOLOGY LETTERS (2016)
Quantification of mutant alleles in circulating tumor DNA can predict survival in lung cancer
Xue Yang et al.
ONCOTARGET (2016)
Identification of Circulating Tumor DNA for the Early Detection of Small-cell Lung Cancer
Lynnette Fernandez-Cuesta et al.
EBIOMEDICINE (2016)
Epidermal growth factor receptor (EGFR) genotyping of matched urine, plasma and tumor tissue from non-small cell lung cancer (NSCLC) patients (pts) treated with rociletinib.
Heather A. Wakelee et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Small Cell Lung Cancer: Will Recent Progress Lead to Improved Outcomes?
M. Catherine Pietanza et al.
CLINICAL CANCER RESEARCH (2015)
Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin
Matthew G. Oser et al.
LANCET ONCOLOGY (2015)
Circulating Tumor Cells in Lung Cancer: Detection Methods and Clinical Applications
Na Yu et al.
LUNG (2015)
Comprehensive genomic profiles of small cell lung cancer
Julie George et al.
NATURE (2015)
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
Giulia Siravegna et al.
NATURE MEDICINE (2015)
RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer
Matthew J. Niederst et al.
NATURE COMMUNICATIONS (2015)
Heterogeneity Underlies the Emergence of EGFRT790 Wild-Type Clones Following Treatment of T790M-Positive Cancers with a Third-Generation EGFR Inhibitor
Zofia Piotrowska et al.
CANCER DISCOVERY (2015)
Prognostic Significance of Circulating Tumor Cells in Small-Cell Lung Cancer Patients: a Meta-analysis
Jiao Zhang et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Prognostic value of circulating tumor cells' reduction in patients with extensive small-cell lung cancer
Nicola Normanno et al.
LUNG CANCER (2014)
Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer
Cassandra L. Hodgkinson et al.
NATURE MEDICINE (2014)
Circulating tumor cells as a prognostic factor in patients with small cell lung cancer
Satoshi Igawa et al.
ONCOLOGY LETTERS (2014)
A multicenter pilot study examining the role of circulating tumor cells as a blood-based tumor marker in patients with extensive small-cell lung cancer
Chao H. Huang et al.
FRONTIERS IN ONCOLOGY (2014)
CK-19 mRNA-positive cells in peripheral blood predict treatment efficacy and survival in small-cell lung cancer patients
Wei-Lin Shi et al.
MEDICAL ONCOLOGY (2013)
Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients
Xiaohui Ni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor
T. J. N. Hiltermann et al.
ANNALS OF ONCOLOGY (2012)
Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer
Jian-Mei Hou et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Prognostic Impact of Circulating Tumor Cells in Patients with Small Cell Lung Cancer
Tateaki Naito et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer
Charles M. Rudin et al.
NATURE GENETICS (2012)
Evaluation of Circulating Tumor Cells and Serological Cell Death Biomarkers in Small Cell Lung Cancer Patients Undergoing Chemotherapy
Jian-Mei Hou et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
A live biopsy in a small-cell lung cancer patient by detection of circulating tumor cells
Simona Bevilacqua et al.
LUNG CANCER (2009)
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Alessandro Liberati et al.
PLOS MEDICINE (2009)
Isolation and extraction of circulating tumor DNA from patients with small cell lung cancer
Ruth E. Board et al.
CIRCULATING NUCLEIC ACIDS IN PLASMA AND SERUM V (2008)
Practical methods for incorporating summary time-to-event data into meta-analysis
Jayne F. Tierney et al.
TRIALS (2007)
Monitoring tumour cells in the peripheral blood of small cell lung cancer patients
BY Kularatne et al.
CYTOMETRY (2002)
Microsatellite alterations and TP53 mutations in plasma DNA of small-cell lung cancer patients:: Follow-up study and prognostic significance
R Gonzalez et al.
ANNALS OF ONCOLOGY (2000)
Meta-analysis of observational studies in epidemiology - A proposal for reporting
DF Stroup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
分享论文
